Showing results (891-900 of 2,357) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|February 3, 2007
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson diseaseFabrizio Stocchi, Laura Fabbri, Laszlo Vecsei, et al.
Clinical Neuropharmacology|November 11, 2006
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosisDoron Merims, Meirav Balas, Chava Peretz, et al.
Clinical Neuropharmacology|November 11, 2006
Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasmsLi-Ping Zou, Chang-Huan Ding, Fang Fang, et al.
Clinical Neuropharmacology|November 11, 2006
Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarctionCheng-Hsien Sun, Cheng-Hsien Lu, Tiao-Lai Huang
Clinical Neuropharmacology|October 1, 1991
Antagonist effect of terguride in Parkinson's diseaseS Ruggieri, F Stocchi, F Baronti, et al.
Clinical Neuropharmacology|July 21, 2006
Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosisColin Klein, Tatiana Prokhorov, Alla Miniovich, et al.
Clinical Neuropharmacology|June 15, 2006
Topiramate-induced psychosis in patients with essential tremor: report of 2 casesTheresa A Zesiewicz, Archer Tullidge, Jonathan Tidwell, et al.
Clinical Neuropharmacology|December 4, 2008
The long-term effect of tetrabenazine in the management of Huntington diseaseAlfonso Fasano, Federica Cadeddu, Arianna Guidubaldi, et al.
Clinical Neuropharmacology|December 4, 2008
Treatment of ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar ataxia (types 3 and 14)Theresa A Zesiewicz, Kelly L Sullivan
Clinical Neuropharmacology|December 4, 2008
Reversible encephalopathy due to sulfasalazineSenem E Mut, Gulnihal Kutlu, Serap Ucler, et al.
Pageof 236